Read next
October 27, 2018
1 min watch
Save
VIDEO: Oyster Point developing nasal spray for dry eye treatment
Issue: November 25, 2018
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
CHICAGO ― At the Ophthalmology Innovation Summit at AAO, Jeffrey Nau, PhD, president and CEO of Oyster Point Pharma, discusses the company’s progress toward the development of a nasal spray targeting the trigeminal nerve to increase tear production in treating dry eye.
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
